Plunkett Research Online: Biofrontera

BIOFRONTERA (BFRA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Biofrontera AG is active in the field of healthcare in the United Kingdom. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the.....



Biofrontera
Ticker: BFRA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 49 214876320
Fax: 49 2148763290
Address: Hemmelrather Weg 201
Leverkusen, D-51377 Germany

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Hermann LubbertCEO/Other Corporate Officer
Thomas SchafferCFO/Other Corporate Officer
See More
Biofrontera AG is active in the field of healthcare in the United Kingdom. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the.....See More See More

Auditor: Warth & Klein Grant Thornton AG
Legal Advisor: LLR Legerlotzlaschet Rechtsanwalte
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (EUR)Bonus (EUR)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: